Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · REGN · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
66
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Regeneron Pharmaceuticals, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
REGN insider buying and selling by quarter
REGN insider selling · REGN insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · REGN ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
REGN executive sell shares · REGN board member insider trading · REGN insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 5 | $4K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 15 | $11K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 24 | $17K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 15 | $11K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 14 | $10K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 7 | $5K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 4 | $3K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 6 | $4K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 2 | $1K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 5 | $4K | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 1 | $712 | Form 4 |
| May 1, 2026 | RYAN ARTHUR F Director | Sale | 2 | $1K | Form 4 |
| Apr 1, 2026 | RYAN ARTHUR F Director | Sale | 1 | $771 | Form 4 |
| Apr 1, 2026 | RYAN ARTHUR F Director | Sale | 3 | $2K | Form 4 |
| Apr 1, 2026 | RYAN ARTHUR F Director | Sale | 8 | $6K | Form 4 |
| Apr 1, 2026 | RYAN ARTHUR F Director | Sale | 8 | $6K | Form 4 |
| Apr 1, 2026 | RYAN ARTHUR F Director | Sale | 14 | $11K | Form 4 |
| Apr 1, 2026 | RYAN ARTHUR F Director | Sale | 13 | $10K | Form 4 |
| Apr 1, 2026 | RYAN ARTHUR F Director | Sale | 9 | $7K | Form 4 |
| Apr 1, 2026 | RYAN ARTHUR F Director | Sale | 4 | $3K | Form 4 |
| Apr 1, 2026 | RYAN ARTHUR F Director | Sale | 40 | $31K | Form 4 |
| Mar 2, 2026 | RYAN ARTHUR F Director | Sale | 7 | $5K | Form 4 |
| Mar 2, 2026 | RYAN ARTHUR F Director | Sale | 2 | $2K | Form 4 |
| Mar 2, 2026 | RYAN ARTHUR F Director | Sale | 5 | $4K | Form 4 |
| Mar 2, 2026 | RYAN ARTHUR F Director | Sale | 3 | $2K | Form 4 |
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About REGN insider trading
REGN insider trades
Regeneron Pharmaceuticals, Inc. (REGN) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including RYAN ARTHUR F (Director), Zoghbi Huda Y (Director), Pitofsky Jason (SVP Controller). Over the past 12 months, 5 insiders have filed transactions with the SEC. REGN insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Regeneron Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
REGN insider trading · 5 questionsThe insiders of Regeneron Pharmaceuticals, Inc. (REGN) include executives and directors such as RYAN ARTHUR F (Director), Zoghbi Huda Y (Director), Pitofsky Jason (SVP Controller), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026